Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 6, 2025
Genome-wide
association
studies
have
identified
thousands
of
genetic
variants
associated
with
non-small
cell
lung
cancer
(NSCLC),
however,
it
is
still
challenging
to
determine
the
causal
and
improve
disease
risk
prediction.
Here,
we
applied
massively
parallel
reporter
assays
perform
NSCLC
variant-to-function
mapping
at
scale.
A
total
1249
candidate
were
evaluated,
30
potential
within
12
loci
identified.
Accordingly,
proposed
three
architectures
underlying
susceptibility:
multiple
in
a
single
haplotype
block
(e.g.
4q22.1),
blocks
5p15.33),
variant
20q11.23).
We
developed
modified
polygenic
score
using
from
Chinese
populations,
improving
performance
prediction
450,821
Europeans
UK
Biobank.
Our
findings
not
only
augment
understanding
architecture
susceptibility
but
also
provide
strategy
advance
stratification.
Determining
GWAS
crucial
for
mechanisms.
authors
apply
MPRA
(NSCLC)
scale
propose
distinct
susceptibility.
Bioinformatics,
Journal Year:
2024,
Volume and Issue:
40(4)
Published: March 15, 2024
Abstract
Summary
Admixed
populations,
with
their
unique
and
diverse
genetic
backgrounds,
are
often
underrepresented
in
studies.
This
oversight
not
only
limits
our
understanding
but
also
exacerbates
existing
health
disparities.
One
major
barrier
has
been
the
lack
of
efficient
tools
tailored
for
special
challenges
studies
admixed
populations.
Here,
we
present
admix-kit,
an
integrated
toolkit
pipeline
analyses
Admix-kit
implements
a
suite
methods
to
facilitate
genotype
phenotype
simulation,
association
testing,
architecture
inference,
polygenic
scoring
Availability
implementation
package
is
open-source
available
at
https://github.com/KangchengHou/admix-kit.
Additionally,
users
can
use
designed
simulation
https://github.com/UW-GAC/admix-kit_workflow.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 22, 2024
Combining
information
from
multiple
GWASs
for
a
disease
and
its
risk
factors
has
proven
powerful
approach
development
of
polygenic
scores
(PRSs).
This
may
be
particularly
useful
type
2
diabetes
(T2D),
highly
heterogeneous
where
the
additional
predictive
value
PRS
is
unclear.
Here,
we
use
meta-scoring
to
develop
metaPRS
T2D
that
incorporated
genome-wide
associations
both
European
non-European
genetic
ancestries
factors.
We
evaluated
performance
this
benchmarked
it
against
existing
in
620,059
participants
50,572
cases
amongst
six
diverse
UK
Biobank,
INTERVAL,
All
Us
Research
Program,
Singapore
Multi-Ethnic
Cohort.
show
our
was
most
predicting
population-based
cohorts
had
comparable
top
ancestry-specific
PRS,
highlighting
transferability.
In
stronger
power
10-year
than
all
individual
apart
BMI
biomarkers
dysglycemia.
The
modestly
improved
stratification
QDiabetes
prediction,
when
prioritising
individuals
blood
tests
Overall,
present
transferrable
demonstrate
potential
incrementally
improve
prediction
into
guideline-recommended
screening
with
clinical
score.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 2, 2025
Polygenic
prediction
has
yet
to
make
a
major
clinical
breakthrough
in
precision
medicine
and
psychiatry,
where
the
application
of
polygenic
risk
scores
is
expected
improve
decision-making.
Most
widely
used
approaches
for
estimating
are
based
on
summary
statistics
from
external
large-scale
genome-wide
association
studies,
which
rely
assumptions
matching
data
distributions.
This
may
hinder
impact
modern
diverse
populations
due
small
differences
genetic
architectures.
Reference-free
estimators
instead
genomic
best
linear
unbiased
predictions
model
population
interest
directly.
We
introduce
framework,
named
hapla,
with
novel
algorithm
clustering
haplotypes
phased
genotype
estimate
heritability
perform
reference-free
complex
traits.
utilize
inferred
haplotype
clusters
compute
accurate
estimates
simulation
study
iPSYCH2012
case-cohort
depression
disorders
schizophrenia.
demonstrate
that
our
haplotype-based
approach
robustly
outperforms
standard
genotype-based
approaches,
can
help
pave
way
future
psychiatry.
Here
authors
develop
framework
leverage
information
through
estimation
prediction.
Their
disease
more
accurately
than
existing
methods,
paving
advancements
personalized
medicine.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 31, 2025
Pancreatic
cysts,
particularly
intraductal
papillary
mucinous
neoplasms
(IPMNs),
pose
a
potential
risk
for
progressing
to
pancreatic
cancer
(PC).
This
study
investigates
the
genetic
architecture
of
benign
cysts
and
its
connection
PC
using
genome-wide
association
studies
(GWAS).
The
discovery
GWAS
identified
significant
variants
associated
with
specifically
rs142409042
variant
near
OPCML
gene.
A
pairwise
comparing
revealed
rs7190458
BCAR1
CTRB1
genes.
Further
analysis
genes
highlighted
Actin
Related
Protein
(Arp)
2/3
complex
as
potentially
important
molecular
mechanism
connecting
PC.
Arp2/3
complex-associated
were
significantly
upregulated
in
PC,
suggesting
their
role
malignant
transformation
cysts.
Differential
expression
these
was
observed
across
various
cell
types
indicating
involvement
tumor
microenvironment.
These
findings
suggest
that
can
serve
biomarkers
predicting
opening
new
avenues
targeted
therapies
early
detection
strategies.
Development and Psychopathology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 15
Published: Jan. 31, 2025
Polygenic
scores
(PGSs)
have
garnered
increasing
attention
in
the
clinical
sciences
due
to
their
robust
prediction
signals
for
psychopathology,
including
externalizing
(EXT)
behaviors.
However,
studies
leveraging
PGSs
rarely
accounted
phenotypic
and
developmental
heterogeneity
EXT
outcomes.
We
used
National
Longitudinal
Study
of
Adolescent
Adult
Health
(analytic
N
=
4,416),
spanning
ages
13
41,
examine
associations
between
trajectories
antisocial
behaviors
(ASB)
substance
use
(SUB)
identified
via
growth
mixture
modeling.
Four
ASB
were
identified:
High
Decline
(3.6%
sample),
Moderate
(18.9%),
Adolescence-Peaked
(10.6%),
Low
(67%),
while
three
SUB:
Use
(35.2%),
Typical
(41.7%),
(23%).
consistently
associated
with
persistent
SUB
(High
Use,
respectively),
relative
comparison
groups.
also
trajectory
SUB,
group.
Results
suggest
may
be
sensitive
typologies
EXT,
where
are
more
strongly
predictive
chronicity
addition
(or
possibly
rather
than)
absolute
severity.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 3, 2025
Abstract
Polygenic
risk
scores
(PRS)
in
Parkinson’s
disease
(PD)
are
associated
with
risk.
Recently,
pathway-specific
PRS
have
been
created
to
take
advantage
of
annotations
inking
variants
biological
pathways
or
cell
types.
Here,
we
investigated
8
regions
open
chromatin
using
PRS:
alpha-synuclein
pathway,
adaptive
immunity,
innate
lysosomal
pathway1,
endocytic
membrane-trafficking
mitochondrial
microglial
single
nucleotide
polymorphisms
(SNPs),
and
monocyte
SNPs.
We
analysed
7,402
PD
patients
across
18
‘in-person’
cohorts,
6,717
from
the
online
Fox
Insight
study.
did
not
find
any
significant
associations
between
PRSs
clinical
outcomes
PD.
Though
this
may
be
due
a
lack
statistical
power
limited
sample
size,
it
also
suggest
that
genetic
architecture
sporadic
is
different
genetics
progression
outcomes.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 13, 2023
Polygenic
risk
scores
(PRS)
are
now
showing
promising
predictive
performance
on
a
wide
variety
of
complex
traits
and
diseases,
but
there
exists
substantial
gap
across
different
populations.
We
propose
MUSSEL,
method
for
ancestry-specific
polygenic
prediction
that
borrows
information
in
the
summary
statistics
from
genome-wide
association
studies
(GWAS)
multiple
ancestry
groups.
MUSSEL
conducts
Bayesian
hierarchical
modeling
under
MUltivariate
Spike-and-Slab
model
effect-size
distribution
incorporates
an
Ensemble
Learning
step
using
super
learner
to
combine
tuning
parameter
settings
In
our
simulation
data
analyses
16
four
distinct
studies,
totaling
5.7
million
participants
with
ancestral
diversity,
shows
compared
alternatives.
The
method,
example,
has
average
gain
R
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 29, 2024
Abstract
Polygenic
scores
(PGSs),
increasingly
used
in
clinical
settings,
frequently
include
many
genetic
variants,
with
performance
typically
peaking
at
thousands
of
variants.
Such
highly
parameterized
PGSs
often
variants
that
do
not
pass
a
genome-wide
significance
threshold.
We
propose
mathematical
perspective
renders
the
effects
these
nonsignificant
random
rather
than
causal,
randomness
capturing
population
structure.
devise
methods
to
assess
variant
effect
and
stratification
bias.
Applying
141
traits
from
UK
Biobank,
we
find
that,
for
PGSs,
non-significant
are
considerably
random,
extent
associated
degree
overfitting
structure
discovery
cohort.
Our
findings
explain
why
simultaneously
have
superior
cohort-specific
limited
generalizability,
suggesting
critical
need
tests
PGS
evaluation.
Supporting
code
dashboard
available
https://github.com/songlab-cal/StratPGS
.